CGEM
Cullinan Oncology LLC
NASDAQ: CGEM · HEALTHCARE · BIOTECHNOLOGY
$12.85
+0.31% today
Updated 2026-04-29
Market cap
$837.68M
P/E ratio
—
P/S ratio
25.86x
EPS (TTM)
$-3.36
Dividend yield
—
52W range
$6 – $17
Volume
0.8M
Cullinan Oncology LLC (CGEM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-44.00%
ROA
-28.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | — | — | — | — |
| 2013 | $0.00 | $-704663.00 | — | — | — |
| 2014 | $0.00 | $-130537.00 | — | — | — |
| 2015 | $0.00 | $-109510.00 | — | — | — |
| 2016 | $0.00 | $-316703.00 | — | — | — |
| 2018 | $0.00 | $-14.19M | — | — | — |
| 2019 | $0.00 | $-20.04M | — | — | — |
| 2020 | $18.94M | $-50.85M | -0.33% | -318.51% | -268.43% |
| 2021 | $18.94M | $-65.04M | 100.00% | -358.73% | -343.35% |
| 2022 | $0.00 | $111.21M | — | — | — |
| 2023 | $0.00 | $-153.16M | — | — | — |
| 2024 | $0.00 | $-167.38M | — | — | — |
| 2025 | $0.00 | $-219.88M | — | — | — |